The leaves of Lindera aggregata (L. aggregata-L), which contain unspecified bioactive components, are a popular tea known for their lipid-regulating properties. This study established a novel and efficient strategy utilizing hybrid lipase–proline metal-organic framework (MOF), combined with HPLC-Q-TOF-MS/MS and molecular docking techniques, to identify potent lipase inhibitors in L. aggregata-L. Porcine pancreatic lipase (PPL) was immobilized within a zeolitic imidazolate framework through biomineralization, and proline was employed to enhance enzyme stability. Consequently, seven lipase inhibitors were initially identified using HPLC-Q-TOF-MS/MS and were subsequently confirmed through nuclear magnetic resonance (NMR) analysis. Their inhibitory activities were validated through an in vitro lipase inhibitory assay. Notably, quercetin-5-O-β-D-glucoside, quercetin-3-O-α-D-xyloside, quercetin-3-O-α-L-arabinofuranoside, and kaempferol-7-O-α-L-rhamnopyranoside were identified as novel lipase inhibitors. The mechanisms of their inhibition were preliminarily investigated through molecular docking and molecular dynamics simulations. This research provided valuable chemical insights into L. aggregata-L for the development of health foods and pharmaceuticals, particularly as a source of natural lipid-regulating drugs.
Publications
- Article type
- Year
- Co-author
Article type
Year
Open Access
Research Article
Issue
Food & Medicine Homology 2026, 3(4): 9420097
Published: 31 March 2025
Downloads:528
Total 1
京公网安备11010802044758号